Morfin Orifarm (Morphine Hydrochloride Trihydrate)

Morphine Hydrochloride acts on the opioid pain pathway to provide potent analgesia in several clinical settings.

• Severe acute pain: provides rapid relief of intense pain episodes.
• Postoperative pain: helps control pain after surgical procedures.
• Cancer pain: offers long‑term management of malignant disease‑related pain.

• Morphine Hydrochloride Trihydrate is a full agonist at the µ‑opioid receptors in the central nervous system. Binding activates inhibitory G‑protein pathways, reducing neuronal excitability, decreasing the release of neurotransmitters such as substance P, and ultimately diminishing the perception of pain.

Morphine may cause a range of adverse reactions, from mild to life‑threatening.

Common Side Effects

• Nausea and vomiting: gastrointestinal upset common after dosing.
• Constipation: reduced bowel motility leading to hard stools.
• Drowsiness: sedation or feeling of tiredness.
• Pruritus: itching, often localized.
• Dry mouth: reduced salivation.
• Urinary retention: difficulty emptying the bladder.

Serious or Rare Side Effects

• Respiratory depression: slowed breathing that can be fatal.
• Hypotension: significant drop in blood pressure.
• Severe allergic reaction: rash, swelling, or anaphylaxis.
• Dependence and withdrawal: physical dependence with abrupt cessation.
• Neurotoxicity: rare excitatory phenomena such as agitation.
• Cardiac arrhythmia: irregular heart rhythm in susceptible patients.

Morphine requires careful monitoring and adherence to safety guidelines.

• Dose titration: adjust dose gradually based on patient response and tolerance.
• Respiratory monitoring: observe for signs of shallow breathing, especially after initiation.
• Concomitant CNS depressants: avoid or limit use with other sedatives.
• Renal/hepatic impairment: use lower doses and monitor function.
• Pregnancy and lactation: assess risk‑benefit; limited data available.
• Store at controlled room temperature: keep in original container, protect from light and moisture.

Morphine can interact with several drug classes, altering its safety or efficacy.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): risk of severe serotonin syndrome.
• Other opioids: additive respiratory depression.
• Central nervous system depressants (e.g., barbiturates): profound sedation.
• CYP3A4 inhibitors (e.g., ketoconazole): increased plasma concentrations.
• Respiratory depressants (e.g., benzodiazepines): heightened risk of respiratory failure.

Moderate Interactions (Monitor Closely)

• Alcohol: may enhance sedative effects.
• Anticholinergics: can worsen constipation.
• Diuretics: may increase risk of hypotension.
• Antihistamines: additive drowsiness.
• CYP2D6 inhibitors: modest increase in opioid effect.